DE60228429D1 - Medizinische zusammensetzung, die ein 1,3-thiazinderivat enthält - Google Patents

Medizinische zusammensetzung, die ein 1,3-thiazinderivat enthält

Info

Publication number
DE60228429D1
DE60228429D1 DE60228429T DE60228429T DE60228429D1 DE 60228429 D1 DE60228429 D1 DE 60228429D1 DE 60228429 T DE60228429 T DE 60228429T DE 60228429 T DE60228429 T DE 60228429T DE 60228429 D1 DE60228429 D1 DE 60228429D1
Authority
DE
Germany
Prior art keywords
composition containing
medical composition
thiazine derivative
optionally substituted
thiazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60228429T
Other languages
English (en)
Inventor
Hiroyuki Kai
Takami Murashi
Minoru Tomida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of DE60228429D1 publication Critical patent/DE60228429D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems
DE60228429T 2001-03-08 2002-02-14 Medizinische zusammensetzung, die ein 1,3-thiazinderivat enthält Expired - Lifetime DE60228429D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001065386 2001-03-08
PCT/JP2002/001229 WO2002072562A1 (fr) 2001-03-08 2002-02-14 Preparation medicinale contenant un derive de 1,3-thiazine

Publications (1)

Publication Number Publication Date
DE60228429D1 true DE60228429D1 (de) 2008-10-02

Family

ID=18924048

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60228429T Expired - Lifetime DE60228429D1 (de) 2001-03-08 2002-02-14 Medizinische zusammensetzung, die ein 1,3-thiazinderivat enthält

Country Status (11)

Country Link
US (1) US6916806B2 (de)
EP (1) EP1375489B1 (de)
JP (1) JP4188694B2 (de)
KR (2) KR20060029296A (de)
CN (1) CN1301981C (de)
AT (1) ATE405555T1 (de)
BR (1) BR0207966A (de)
CA (1) CA2440186C (de)
DE (1) DE60228429D1 (de)
MX (1) MXPA03008033A (de)
WO (1) WO2002072562A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE393150T1 (de) * 1999-09-14 2008-05-15 Shionogi & Co 2-imino-1,3-thiazin-derivate
EP2130820A1 (de) * 2002-02-19 2009-12-09 Shionogi & Co., Ltd. Antipruriginosa
WO2005016351A1 (ja) * 2003-08-18 2005-02-24 Shionogi & Co., Ltd. カンナビノイド受容体アゴニストの新規用途
TW200508211A (en) * 2003-08-26 2005-03-01 Shionogi & Co 2-naphthylimino-1,3-thiazine derivatives
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
JPWO2006080284A1 (ja) * 2005-01-25 2008-06-19 塩野義製薬株式会社 ２−置換イミノ−１，３−オキサジン誘導体
WO2006080287A1 (ja) * 2005-01-25 2006-08-03 Shionogi & Co., Ltd. ２－アゾリルイミノ－１，３－チアジン誘導体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165894A (ja) 1984-09-08 1986-04-04 Shionogi & Co Ltd チアジンホスホン酸誘導体とその製法および殺虫剤
JPS6229594A (ja) 1985-07-31 1987-02-07 Shionogi & Co Ltd チアジン環を有する有機燐化合物
JPS62120374A (ja) 1985-11-20 1987-06-01 Yoshitomi Pharmaceut Ind Ltd １，３−チアジンまたは１，３−オキサジン誘導体
NL8702437A (nl) 1987-10-13 1989-05-01 Geo Kinetics B V I O Werkwijze voor het conditioneren van grondmateriaal door elektrokinetische behandeling, elektrisch stroomsysteem voor toepassing van de werkwijze alsmede elektrode-behuizing voor toepassing in het elektrische stroomsysteem.
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5194434A (en) * 1991-12-03 1993-03-16 Texas A&M University System Use of OB-101 to treat ocular inflammation
KR19990082330A (ko) * 1996-02-06 1999-11-25 미즈노 마사루 신규 화합물 및 이의 의약 용도
WO1998041519A1 (en) 1997-03-18 1998-09-24 Smithkline Beecham Corporation Novel cannabinoid receptor agonists
KR20010021696A (ko) 1997-07-11 2001-03-15 미즈노 마사루 퀴놀린 화합물 및 그의 의약용도
DE19837627A1 (de) * 1998-08-19 2000-02-24 Bayer Ag Neue Aminosäureester von Arylsulfonamiden und Analoga
CZ20012530A3 (cs) * 1999-01-14 2002-02-13 Bayer Corporation Substituované 2-aryliminoheterocykly a prostředky s jejich obsahem, k pouľití jako činidla vázajícího receptor progesteronu
ATE393150T1 (de) 1999-09-14 2008-05-15 Shionogi & Co 2-imino-1,3-thiazin-derivate

Also Published As

Publication number Publication date
ATE405555T1 (de) 2008-09-15
WO2002072562A1 (fr) 2002-09-19
JPWO2002072562A1 (ja) 2004-07-02
CA2440186A1 (en) 2002-09-19
EP1375489B1 (de) 2008-08-20
CN1301981C (zh) 2007-02-28
CA2440186C (en) 2009-01-13
KR20060029296A (ko) 2006-04-05
BR0207966A (pt) 2004-06-15
EP1375489A1 (de) 2004-01-02
KR100642570B1 (ko) 2006-11-10
MXPA03008033A (es) 2003-12-04
US6916806B2 (en) 2005-07-12
US20040116326A1 (en) 2004-06-17
KR20040007462A (ko) 2004-01-24
CN1514831A (zh) 2004-07-21
JP4188694B2 (ja) 2008-11-26
EP1375489A4 (de) 2005-03-02

Similar Documents

Publication Publication Date Title
HK1046639A1 (en) Nitroimidazole external preparations for dermatosis
NO953305L (no) Antranilsyrederivat
DE60038687D1 (de) 2-imino-1,3-thiazin-derivate
ATE190052T1 (de) Thiazolidindione-derivate, ihre herstellung und verwendung
DK0807630T3 (da) Heterocykliske forbindelser
DE69511424D1 (de) Antifungale sordaridinderivate
ATE289810T1 (de) Ecteinascidinderivate
PE34996A1 (es) Nuevo derivado de pirrocarbazol
ATE122344T1 (de) Naphthyloxazolidon-derivate.
DE60228429D1 (de) Medizinische zusammensetzung, die ein 1,3-thiazinderivat enthält
DK1031556T3 (da) 2-phenoxyanilinderivater
MXPA03008250A (es) Nuevos derivados de diaminopirazol y colorantes que contienen estos compuestos.
DK1559714T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-3-aminothiophenderivater og 3-aminothiophenderivater
TR200200347T2 (tr) 1,4-İkameli 4,4-diaril sikloheksanlar.
EP1211253A4 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
DE69906243D1 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
CA2297112A1 (en) Dicyclanil polymorphs and hydrates and their preparation
ATE340175T1 (de) Imidazo(4,5-böchinolinderivate und ihre verwendung als inhibitoren der induzierbaren no- synthase
EP1148059A4 (de) Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung
DE59905342D1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
TH26544A (th) อนุพันธ์กรด -4 - อัลคิลไทโอ -ไพรมิดิน -5 - อิล อาซีติก

Legal Events

Date Code Title Description
8364 No opposition during term of opposition